Pol, Stanislas

Publishing since 1989 (Dinosaur)

Has published 261 publications in 22 years

Number of publications published per year by Pol, Stanislas. (Source : PubMed)

Distribution of publications types for Pol, Stanislas. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Mallet VO, Sultanik PS, Vallet-Pichard A, Pol S. HIV-associated obliterative portopathy (HIV-OP) underlies cryptogenic liver disease in HIV-seropositive patients.  HIV Med.  2010  
•  Mallet V, Vallet-Pichard A, Pol S. New trends in hepatitis C management.  Presse Med  2010  
•  Scott-Algara D, Mancini-Bourgine M, Fontaine H, Pol S, Michel ML. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination.  PLoS ONE  2010;5;1  
•  Nascimbeni M, Montange T, Law HK, Mallet V, Saunier B, Rivière Y, Pol S. Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.  Hepatology  2010;51;1  
•  Pol S, Bharadwaj R. Evaluation of high performance liquid chromatography purified leptospiral antigen for the diagnosis of leptospirosis.  Jpn. J. Infect. Dis.  2009;62;6  
•  Loulergue P, Pol S, Mallet V, Sogni P, Launay O. Why actively promote vaccination in patients with cirrhosis?  J. Clin. Virol.  2009;46;3  
•  El Makhzangy H, Esmat G, Said M, Elraziky M, Shouman S, Refai R, Rekacewicz C, Gad RR, Vignier N, Abdel-Hamid M, Zalata K, Bedossa P, Pol S, Fontanet A, Mohamed MK. Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.  J. Med. Virol.  2009;81;9  
•  Trabut JB, Mallet V, Pol S. Aspartate aminotransferase to platelet ratio index (APRI) score is inappropriate for assessment of liver fibrosis in HIV-infected patients with hazardous drinking.  HIV Med.  2009;10;8  
•  Bani-Sadr F, Barange K, Daoud F, Jacomet C, Bicart-See A, Rosenthal E, Cacoub P, Pol S, Perronne C, Carrat F. Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.  HIV Med.  2009;10;7  
•  Mallet VO, Vallet-Pichard A, Pol S. Human immunodeficiency virus-associated obliterative portopathy underlies unexplained aminotransferase elevations under antiretrovirals.  Hepatology  2009;50;2  

[ See timeline ] [ See all publications ]